194 related articles for article (PubMed ID: 7292644)
21. [Contraception in preclimacteric women with special regard to oral contraceptives (author's transl)].
Salzer H; Schneider WH; Eppel W
Wien Med Wochenschr; 1980 Mar; 130(6):218-21. PubMed ID: 7395249
[TBL] [Abstract][Full Text] [Related]
22. [On the problem of increased risk of thrombosis in short- and long-term therapy with oral ovulation inhibitors].
Halberstadt E; Brehm H; Wüst L; Lüters I; Kollmar I
Med Welt; 1968 Mar; 13():806-10 passim. PubMed ID: 5709919
[No Abstract] [Full Text] [Related]
23. [Spontaneous mesenteric venous thrombosis, a rare complication of oral contraceptives (author's transl)].
Hofbauer F; Depisch D; Skodler D
Wien Klin Wochenschr; 1980 Mar; 92(6):191-4. PubMed ID: 7395232
[TBL] [Abstract][Full Text] [Related]
24. Effects of oral and transdermal hormonal contraception on vascular risk markers: a randomized controlled trial.
Johnson JV; Lowell J; Badger GJ; Rosing J; Tchaikovski S; Cushman M
Obstet Gynecol; 2008 Feb; 111(2 Pt 1):278-84. PubMed ID: 18238963
[TBL] [Abstract][Full Text] [Related]
25. Inferior vena cava thrombosis with oral contraceptives documented by computed tomography.
Barter JF; Addison WA; Hidalgo H; Hammond CB
Obstet Gynecol; 1983 Mar; 61(3 Suppl):59S-62S. PubMed ID: 6681670
[No Abstract] [Full Text] [Related]
26. [Who is still afraid of the pill today? The development of hormonal contraception ('the pill') in the last 20 years. Current status].
van Vliet M
Tijdschr Ziekenverpl; 1982 Oct; 35(20):659-63. PubMed ID: 6923669
[No Abstract] [Full Text] [Related]
27. [Examination of the periodontium in women taking contraceptive pills].
Korondy M; Székely Z; Szepesi L
Fogorv Sz; 1976; 69 Suppl():428-9. PubMed ID: 1072000
[No Abstract] [Full Text] [Related]
28. [APC (activated protein C) resistance and oral contraceptives].
Kreis I; Weiss T; Rabe TN; Ziegler R; Nawroth PP
Geburtshilfe Frauenheilkd; 1996 May; 56(5):231-3. PubMed ID: 8768059
[TBL] [Abstract][Full Text] [Related]
29. Effects of second and third generation oral contraceptives and their respective progestagens on the coagulation system in the absence or presence of the factor V Leiden mutation.
Kemmeren JM; Algra A; Meijers JC; Bouma BN; Grobbee DE
Thromb Haemost; 2002 Feb; 87(2):199-205. PubMed ID: 11859850
[TBL] [Abstract][Full Text] [Related]
30. Increased levels of activated factor VII and decreased plasma protein S activity and circulating thrombomodulin during use of oral contraceptives.
Quehenberger P; Loner U; Kapiotis S; Handler S; Schneider B; Huber J; Speiser W
Thromb Haemost; 1996 Nov; 76(5):729-34. PubMed ID: 8950781
[TBL] [Abstract][Full Text] [Related]
31. [Effect of hormonal contraceptives on the activity of various enzymes in blood serum].
Schädel JM; Rehfeld N
Z Med Lab Diagn; 1985; 26(2):77-85. PubMed ID: 3993167
[No Abstract] [Full Text] [Related]
32. [Oral contraceptives and oral candidiasis].
Krekeler G; Ochs G; Haderthauer W
Fortschr Med; 1981 Feb; 99(7):230-2. PubMed ID: 7216106
[No Abstract] [Full Text] [Related]
33. [Clinical and metabolic effects of oral contraceptives].
Vázquez Hernández L; Téllez Martínez J; Hicks Gómez JJ
Ginecol Obstet Mex; 2000 Feb; 68():64-9. PubMed ID: 10774107
[TBL] [Abstract][Full Text] [Related]
34. [Contraceptive pills and thrombosis].
Helweg-Larsen K; Jensen JB; Jensen LK; Petersson B; Plesner R; Sidenius K; Stoltz-Andersen A
Ugeskr Laeger; 1981 Jan; 143(4):220. PubMed ID: 7256969
[No Abstract] [Full Text] [Related]
35. Oral contraceptives and hypercoagulation.
Petitti DB
Clin Adv Hematol Oncol; 2006 Nov; 4(11):813-5. PubMed ID: 17143250
[No Abstract] [Full Text] [Related]
36. Oral contraception and thrombophilia.
Blickstein D; Blickstein I
Curr Opin Obstet Gynecol; 2007 Aug; 19(4):370-6. PubMed ID: 17625421
[TBL] [Abstract][Full Text] [Related]
37. [The vascular risk of third generation contraceptive pills].
Levesque H; Borg JY; Courtois H
J Mal Vasc; 1997 Mar; 22(1):5-12. PubMed ID: 9120373
[TBL] [Abstract][Full Text] [Related]
38. Judging risks versus benefits of oral contraceptives.
Jones JK; Kennedy DL; Piper JM; Rosa FW
Clin Pharm; 1984; 3(5):521-2. PubMed ID: 6488733
[No Abstract] [Full Text] [Related]
39. [Interactions with the p-pill].
Kristensen MB
Ugeskr Laeger; 1981 Mar; 143(11):698. PubMed ID: 7281282
[No Abstract] [Full Text] [Related]
40. [Can the measurement of antithrombin-3 point out women who run the risk of thrombosis with the use of P-pills?].
Fagerhol MK; Abildgaard U
Tidsskr Nor Laegeforen; 1970 Aug; 90(16):1559-60. PubMed ID: 5457809
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
